The legacy success of sildenafil has undeniably shaped the pharmaceutical landscape. However, wagering in companies heavily dependent on biosimilars and the waning patent exclusivity surrounding this https://lancehkvp209727.blogs-service.com/72107078/the-blue-pill-and-drugmakers-a-uncertain-opportunity